SLC2A1 and colorectal cancer: In addition, anti-GLUT1 antibody (GLUT1) has been used to modify polymeric micelles coloaded with CUR and doxorubicin and have shown increased efficacy in human colorectal cancer cell HCT-166 both in vitro and in vivo [58].